Insulet (PODD) Other Non-Current Assets (2010 - 2026)

Insulet (PODD) posted Other Non-Current Assets of $280.6 million for Q1 2026, down 2.64% on a QoQ basis from $288.2 million in Q4 2025, and down 12.01% year-over-year from $318.9 million in Q1 2025.

Insulet (PODD) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Insulet's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $280.6 million for Q1 2026.

  • Quarterly Other Non-Current Assets fell 12.01% year-over-year to $280.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $280.6 million (down 12.01% YoY) and the FY2025 annual result came in at $288.2 million, up 58.79% from the prior year.
  • Other Non-Current Assets was $280.6 million for Q1 2026 at Insulet, down from $288.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $318.9 million in Q1 2025 and bottomed at $141.0 million in Q1 2022.
  • A 5-year average of $211.1 million and a median of $188.3 million in 2025 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 97.93% — and 2024, when it retreated 22.68%.
  • Insulet's Other Non-Current Assets stood at $210.0 million in 2022, then declined by 10.38% to $188.2 million in 2023, then decreased by 3.56% to $181.5 million in 2024, then jumped by 58.79% to $288.2 million in 2025, then fell by 2.64% to $280.6 million in 2026.
  • Business Quant data shows PODD's Other Non-Current Assets at $280.6 million in Q1 2026, $288.2 million in Q4 2025, and $188.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 3.17 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 2.05 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 738.90 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 285.90 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.25 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 164.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 828.89 Mn
10 Insulet 11.52 Bn 11.04 Bn 529.10 Mn 280.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 280.60 Mn
Dec 31, 2025 288.20 Mn
Sep 30, 2025 188.30 Mn
Jun 30, 2025 315.10 Mn
Mar 31, 2025 318.90 Mn
Dec 31, 2024 181.50 Mn
Sep 30, 2024 165.90 Mn
Jun 30, 2024 163.60 Mn
Mar 31, 2024 187.70 Mn
Dec 31, 2023 188.20 Mn
Sep 30, 2023 196.20 Mn
Jun 30, 2023 211.60 Mn
Mar 31, 2023 210.60 Mn
Dec 31, 2022 210.00 Mn
Sep 30, 2022 178.70 Mn
Jun 30, 2022 161.90 Mn
Mar 31, 2022 141.00 Mn
Dec 31, 2021 106.10 Mn
Sep 30, 2021 99.60 Mn
Jun 30, 2021 92.00 Mn